Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic abnormalities in cachexia and anorexia.

M J Tisdale1

  • 1Pharmaceutical Sciences Research Institute, Aston University, Birmingham, UK. m.j.tisdale@aston.ac.uk

Nutrition (Burbank, Los Angeles County, Calif.)
|October 31, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCg) Attenuates Skeletal Muscle Atrophy in a Rat Model of Sarcopenia.

The Journal of frailty & aging·2016
Same author

Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.

British journal of cancer·2014
Same author

Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle.

Cellular signalling·2012
Same author

Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).

British journal of cancer·2011
Same author

Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat.

International journal of obesity (2005)·2010
Same author

Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse.

International journal of obesity (2005)·2010

Cancer cachexia, characterized by muscle and fat loss, may be countered by eicosapentaenoic acid. This fatty acid shows promise in stabilizing body weight and reserves in cancer patients, warranting further investigation.

Area of Science:

  • Oncology
  • Metabolic Medicine
  • Nutritional Science

Background:

  • Solid tumors increase metabolic demand, leading to elevated energy expenditure.
  • Cancer cachexia involves depletion of adipose tissue and skeletal muscle mass.
  • A 24 kDa glycoprotein from tumors induces muscle catabolism and cachexia.

Purpose of the Study:

  • To investigate the role of a tumor-derived glycoprotein in cancer cachexia.
  • To evaluate the effect of eicosapentaenoic acid (EPA) on muscle catabolism.
  • To assess EPA's potential in stabilizing body weight and reserves in cancer patients.

Main Methods:

  • In vitro studies on muscle catabolism induced by a proteolysis-inducing factor (PIF).
  • In vivo studies assessing cachexia induction by PIF.

Related Experiment Videos

  • Preliminary clinical trials with EPA in pancreatic carcinoma patients.

    • Main Results:

    • The PIF's bioactivity was attenuated by eicosapentaenoic acid in vitro.
    • EPA stabilized body weight and protein/fat reserves in preliminary pancreatic cancer patient studies.
    • The PIF specifically caused loss of non-fat carcass mass.

    Conclusions:

    • Eicosapentaenoic acid demonstrates potential as an anticachectic agent.
    • EPA may counteract tumor-induced muscle catabolism.
    • Further clinical trials are needed to confirm EPA's efficacy in various cancers.